Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan
Helus Pharma announced the addition of Dr. Robert Langer, a biotech pioneer, and Dr. Stephen Brannan, an experienced CNS clinical development leader, to its Scientific Advisory Board. This strategic move strengthens the company’s expertise as it advances its pipeline of novel serotonergic agonists aimed at treating major depressive disorder and gen…